Table 3.

Confirmation of select gene changes by quantitative RT-PCR

RT-PCR Microarray
UniGene Gene Ratio p value Ratio p value
Hippocampus, chronic ECS
    Rn.964 Insulin-like growth factor II (somatomedin A) 0.33 4.4E-02 0.44 5E-02
    Rn.11400 Prostaglandin D synthase 0.34 3.9E-02 0.35 6E-03
    Rn.19727 Hairy and enhancer of split 1 (Drosophila) 1.27 1.8E-02 2.09 5E-03
    Rn.18568 Rat smallest neurofilament protein (NF-L) mRNA 1.31 2.1E-03 1.22 4E-02
    Rn.7044 Glypican 1 1.33 1.6E-02 1.28 3E-04
    Rn.78188 Heme oxygenase-3 (H0-3) mRNA 1.42 2.3E-02 1.61 9E-03
    Rn.859 Ras homolog enriched in brain 1.54 6.7E-04 1.45 3E-03
    Rn.9756 Protein phosphatase 1, regulatory (inhibitor) subunit 1A 1.58 4.8E-06 1.62 6E-03
    Rn.3546 Neuritin 1.58 8.6E-05 1.44 8E-04
    Rn.31799 Pyruvate dehydrogenase phosphatase isoenzyme 1 1.72 1.3E-03 1.83 2E-02
    Rn.9714 Neuropeptide Y 2.40 5.2E-06 2.14 1E-02
    Rn.22 Thyrotropin releasing hormone 21.42 1.8E-03 2.01 1E-02
Hippocampus, acute ECS
    Rn.87787 Glutamate receptor, metabotropic 1 0.63 2.5E-06 0.60 3E-05
    Rn.19727 Hairy and enhancer of split 1 (Drosophila) 0.71 3.3E-02 1.55 4E-05
    Rn.3812 Normalized rat heart, Bento Soares Rattus sp. cDNA RHEAE07 0.72 1.4E-05 0.65 2E-03
    Rn.9113 Aldehyde dehydrogenase family 3, subfamily A2 0.86 5.6E-03 0.44 2E-05
    Rn.3360 Growth factor receptor bound protein 2 1.36 3.1E-02 1.68 6E-06
    Rn.10815 Neuropilin 1.36 1.2E-04 1.67 2E-03
    Rn.9797 Fibroblast growth factor receptor 1 1.44 1.6E-03 1.51 2E-03
    Rn.2045 Protein tyrosine phosphatase type IVA, member 2 1.46 2.0E-03 1.51 3E-03
    Rn.3546 Neuritin 1.59 4.9E-06 1.56 1E-08
    Rn.9839 Nuclear receptor subfamily 4, group A, member 2 1.76 6.8E-05 1.70 1E-05
    Rn.44320 Avian sarcoma virus 17 (v-jun) oncogene homolog 1.80 1.7E-07 1.84 9E-05
    Rn.859 Ras homolog enriched in brain 1.83 1.0E-07 1.42 1E-05
    Rn.11183 DNA-damage inducible transcript 3 1.89 1.6E-08 1.78 4E-03
    Rn.3723 IFN-related developmental regulator 1 1.93 1.3E-07 2.01 3E-05
    D82074 Rattus sp. mRNA for BHF-1 1.97 7.0E-04 0.44 6E-04
    S65091 cAMP-regulated phosphoprotein 2.52 6.7E-05 2.09 7E-07
    Rn.2398 TGFB inducible early growth response 2.79 1.4E-08 3.62 1E-06
    Rn.40517 Activity and neurotransmitter-induced early gene protein 4 (ania-4) 3.64 2.9E-10 2.58 6E-07
    Rn.44369 Prostaglandin-endoperoxide synthase 2 4.03 1.5E-07 7.33 9E-08
    Rn.25754 Tissue inhibitor of metalloproteinase 1 4.71 8.7E-08 11.39 2E-06
    Rn.11266 Brain-derived neurotrophic factor 5.73 2.9E-08 3.85 2E-04
    S82649 Neuronal activity-regulated pentraxin 7.24 2.0E-10 5.89 7E-09
    Rn.37500 Homer, neuronal immediate early gene, 1 7.42 2.5E-07 6.50 2E-07
Frontal cortex, chronic ECS
    Rn.11400 Prostaglandin D synthase 0.61 1.0E-02 0.71 0.03
    Rn.7730 Prostaglandin E synthase 2.18 1.5E-02 not on U34A chip
    Rn.506 Synapsin 2 1.29 1.0E-03 1.34 0.0004
Frontal cortex, acute ECS
    Rn.32777 Ceruloplasmin (ferroxidase) 1.35 2.8E-02 1.81 2E-05
    Rn.10599 Phosphoinositide 3-kinase, regulatory subunit, polypeptide 1 1.59 5.8E-04 2.02 4E-03
    Rn.6977 Lost on transformation 1 1.90 2.1E-04 1.58 8E-05
    Rn.1716 Interleukin-6 receptor 2.24 3.1E-08 1.74 3E-05
  • All samples for ECS-treated groups and sham control groups used for microarray studies were analyzed for each gene (n = 8 - 10 per group).